Pathological Left Ventricular Hypertrophy and Stem Cells: Current Evidence and New Perspectives
about
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy.Calcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility.CD38 promotes angiotensin II-induced cardiac hypertrophy.Monitoring of Cardiac Remodeling in a Mouse Model of Pressure-Overload Left Ventricular Hypertrophy with [(18)F]FDG MicroPET.
P2860
Pathological Left Ventricular Hypertrophy and Stem Cells: Current Evidence and New Perspectives
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Pathological Left Ventricular ...... Evidence and New Perspectives
@ast
Pathological Left Ventricular ...... Evidence and New Perspectives
@en
Pathological Left Ventricular ...... Evidence and New Perspectives
@nl
type
label
Pathological Left Ventricular ...... Evidence and New Perspectives
@ast
Pathological Left Ventricular ...... Evidence and New Perspectives
@en
Pathological Left Ventricular ...... Evidence and New Perspectives
@nl
prefLabel
Pathological Left Ventricular ...... Evidence and New Perspectives
@ast
Pathological Left Ventricular ...... Evidence and New Perspectives
@en
Pathological Left Ventricular ...... Evidence and New Perspectives
@nl
P2093
P2860
P356
P1476
Pathological Left Ventricular ...... Evidence and New Perspectives
@en
P2093
Fragiskos Parthenakis
Maria E Marketou
Panos E Vardas
P2860
P304
P356
10.1155/2016/5720758
P407
P577
2016-01-01T00:00:00Z